CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q1 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $581,299 | -18.8% | 5,764 | +9.4% | 0.00% | 0.0% |
| Q2 2023 | $716,140 | +50.2% | 5,270 | +14.8% | 0.00% | +50.0% |
| Q1 2023 | $476,821 | +17.2% | 4,591 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $406,946 | +34.3% | 4,591 | +21.6% | 0.00% | 0.0% |
| Q3 2022 | $303,000 | -16.1% | 3,775 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $361,000 | -35.7% | 3,775 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $561,000 | +4.9% | 3,775 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $535,000 | +40.1% | 3,775 | +29.4% | 0.00% | +50.0% |
| Q3 2021 | $382,000 | -4.7% | 2,918 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $401,000 | +5.2% | 2,918 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $381,000 | -7.5% | 2,918 | -20.6% | 0.00% | -33.3% |
| Q4 2020 | $412,000 | +59.7% | 3,675 | +12.2% | 0.00% | +50.0% |
| Q3 2020 | $258,000 | +9.3% | 3,276 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $236,000 | +65.0% | 3,276 | +31.3% | 0.00% | +100.0% |
| Q1 2020 | $143,000 | -39.9% | 2,495 | +17.1% | 0.00% | -50.0% |
| Q4 2019 | $238,000 | +16.1% | 2,131 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $205,000 | +12.6% | 2,131 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $182,000 | +58.3% | 2,131 | +53.6% | 0.00% | +100.0% |
| Q1 2019 | $115,000 | -4.2% | 1,387 | -25.6% | 0.00% | 0.0% |
| Q4 2018 | $120,000 | -18.9% | 1,864 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $148,000 | +24.4% | 1,864 | +14.6% | 0.00% | 0.0% |
| Q2 2018 | $119,000 | -2.5% | 1,627 | -15.5% | 0.00% | 0.0% |
| Q1 2018 | $122,000 | +114.0% | 1,926 | +72.1% | 0.00% | 0.0% |
| Q4 2017 | $57,000 | +54.1% | 1,119 | +56.7% | 0.00% | – |
| Q3 2017 | $37,000 | +2.8% | 714 | 0.0% | 0.00% | – |
| Q2 2017 | $36,000 | +12.5% | 714 | 0.0% | 0.00% | – |
| Q1 2017 | $32,000 | 0.0% | 714 | 0.0% | 0.00% | – |
| Q4 2016 | $32,000 | +10.3% | 714 | 0.0% | 0.00% | – |
| Q3 2016 | $29,000 | +7.4% | 714 | +27.3% | 0.00% | – |
| Q2 2016 | $27,000 | +12.5% | 561 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | -4.0% | 561 | 0.0% | 0.00% | – |
| Q4 2015 | $25,000 | +92.3% | 561 | +108.6% | 0.00% | – |
| Q3 2015 | $13,000 | +85.7% | 269 | +140.2% | 0.00% | – |
| Q2 2015 | $7,000 | +16.7% | 112 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |